TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Avansor Pharma Oy
Closing information (x1000 SEK)
Closing information | 2016/12 | 2015/12 | 2014/12 |
Turnover |
18,952
|
11,711
|
15,073 |
Financial expenses |
86
|
46
|
10 |
Earnings before taxes |
7,453
|
3,846
|
3,549 |
Total assets |
37,320
|
30,812
|
27,481 |
Current assets |
17,106
|
5,307
|
7,822 |
Current liabilities |
5,271
|
3,161
|
2,541 |
Equity capital |
29,179
|
24,920
|
24,940 |
- share capital |
306
|
292
|
304 |
Employees (average) | 3 |
Financial ratios
Fiscal year | 2016/12 | 2015/12 | 2014/12 |
Solvency |
78.2%
|
80.9%
|
90.8% |
Turnover per employee | 5,024 | ||
Profit as a percentage of turnover |
39.3%
|
32.8%
|
23.5% |
Return on assets (ROA) |
20.2%
|
12.6%
|
13.0% |
Current ratio |
324.5%
|
167.9%
|
307.8% |
Return on equity (ROE) |
25.5%
|
15.4%
|
14.2% |
Change turnover |
6,687
|
-2,759 | |
Change turnover % |
55%
|
-19% | |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2016/12 | 2015/12 | 2014/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.